GIORGI, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 1.981
EU - Europa 598
AS - Asia 165
SA - Sud America 23
AF - Africa 4
OC - Oceania 4
Totale 2.775
Nazione #
US - Stati Uniti d'America 1.968
IT - Italia 365
IN - India 92
SE - Svezia 61
CN - Cina 57
FI - Finlandia 49
UA - Ucraina 37
BG - Bulgaria 19
DE - Germania 19
BR - Brasile 14
GB - Regno Unito 14
CA - Canada 13
IE - Irlanda 11
AR - Argentina 8
SG - Singapore 8
HK - Hong Kong 6
RO - Romania 6
BE - Belgio 5
FR - Francia 5
AU - Australia 3
CZ - Repubblica Ceca 3
TG - Togo 3
CL - Cile 1
ES - Italia 1
IR - Iran 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
ZA - Sudafrica 1
Totale 2.775
Città #
Fairfield 378
Woodbridge 185
Ashburn 163
Rome 153
Seattle 133
Dearborn 129
Houston 119
Wilmington 102
Cambridge 99
Ann Arbor 71
Chandler 64
Princeton 58
San Paolo di Civitate 51
Plano 46
Lawrence 36
Boston 33
Millbury 26
Beijing 25
San Diego 22
Fremont 19
Sofia 19
Norwalk 18
New York 17
Andover 12
Jacksonville 12
Dublin 11
Toronto 9
Falls Church 8
Federal 8
Boardman 7
Helsinki 7
Bühl 6
Nanjing 6
Brussels 5
Hong Kong 5
Anzio 4
Fasano 4
Ottawa 4
Redwood City 4
Tappahannock 4
Buffalo 3
Campinas 3
Guangzhou 3
Hefei 3
Indiana 3
Jinan 3
Kunming 3
Lomé 3
Milan 3
Phoenix 3
Bremen 2
Catania 2
Kilburn 2
London 2
Riva 2
Shenyang 2
Singapore 2
Sydney 2
Valbonne 2
Verona 2
Auckland 1
Baotou 1
Barrow in Furness 1
Cainta 1
Castelforte 1
Chengdu 1
Chicago 1
Chongqing 1
Des Moines 1
Frascati 1
Fuzhou 1
Gallicano nel Lazio 1
Grugliasco 1
Hangzhou 1
Harbin 1
Hebei 1
Henderson 1
Kish 1
L'aquila 1
La Canada Flintridge 1
Lappeenranta 1
Las Vegas 1
Laurel 1
Manchester 1
Modena 1
Muizenberg 1
Nanchang 1
Naples 1
North Shields 1
Oslo 1
Padova 1
Pune 1
Rocca Di Papa 1
Sant Vicenç dels Horts 1
Wenzhou 1
Wuhan 1
Yellow Springs 1
Totale 2.169
Nome #
Identification of murine phosphodiesterase 5A isoforms and their functional characterization in HL-1 cardiac cell line 120
Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions 102
The oligomeric assembly of the phosphodiesterase-5 is a mixture of dimers and tetramers: a putative role in the regulation of function 91
Metabolic role of cGMP in S. cerevisiae: the murine phosphodiesterase-5 activity affects yeast cell proliferation by altering the cAMP/cGMP equilibrium 87
Egr1 maintains NSC proliferation and its overexpression counteracts cell cycle exit triggered by the withdrawal of Epidermal Growth Factor 85
Phosphodiesterase-10A inverse changes in striatopallidal and striatoentopeduncular pathways of a transgenic mouse model of DYT1 dystonia 80
Expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in mouse tissues and cell lines using an antibody against the enzyme amino-terminal domain 79
Immunohistochemical localisation of PDE5 in Leydig and myoid cells of prepuberal and adult rat testis 77
Expression of PDE5 splice variants during ontogenesis of chick dorsal root ganglia 76
cAMP-dependent induction of PDE5 expression in murine neuroblastoma cell differentiation 72
Increase of Intracellular Cyclic AMP by PDE4 Inhibitors Affects HepG2 Cell Cycle Progression and Survival 71
Fluorometric detection of protein-ligand engagement: The case of phosphodiesterase5 71
Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa 68
Gene expression and protein localization of calmodulin-dependent phosphodiesterase during ontogenesis of chick retina 66
Differential expression and localization of calmodulin-dependent phosphodiesterase genes during ontogenesis of chick dorsal root ganglion 65
Use of the KlADH3 promoter for the quantitative production of the murine PDE5A isoforms in the yeast Kluyveromyces lactis 65
PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology 64
Zaprinast impairs spatial memory by increasing PDE5 expression in the rat hippocampus 61
A preparative method for isolation of peroxisomes from rat kidney. 60
Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: reduced synthesis or increased catabolism? 58
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 57
RANTES and human sperm fertilizing ability: Effect on acrosome reaction and sperm/oocyte fusion 56
Spectrin oligomerization is cooperatively coupled to membrane assembly: A linkage targeted by many hereditary hemolytic anemias? 56
Type 5 phosphodiesterase expression in the human vagina 56
Gene expression and protein localization of calmodulin-dependent phosphodiesterase in adult rat retina 55
The induction of cyclic nucleotide phosphodiesterase 4 gene (PDE4D) impairs memory in a water maze task 55
Subcellular localization and regulation of type-1C and type-5 phosphodiesterases 53
Regulation of phosphodiesterase 5 expression and activity in human pregnant and non-pregnant myometrial cells by human chorionic gonadotropin 53
Immunohistochemical localisation of PDE5 in rat lung during pre-and postnatal development. 52
Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: New aspects in the pathogenetic mechanisms 52
Phosphodiesterase inhibitors: Could they be beneficial for the treatment of COVID-19? 51
Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation 46
A2a receptor dysregulation in dystonia dyt1 knock-out mice 44
Dystonia: sparse synapses for D2 receptors in striatum of a DYT1 knock-out mouse model 43
Targeting cyclic AMP signalling in hepatocellular carcinoma 40
Opposite changes of Phosphodiesterase-10A in striato-pallidal and striato-entopeduncular pathways of TorsinA DYT1 transgenic mice 37
Aflatoxin B1 is an inhibitor of cyclic nucleotide phosphodiesterase activity 36
Phosphodiesterases expression during murine cardiac development 36
Different mouse genetic models of human DYT1 dystonia share changes of phosphodiesterase-10A in basal ganglia circuits. 35
null 35
Phosphodiesterase 5a signalling in skeletal muscle pathophysiology 30
Structural characterization of murine phosphodiesterase 5 isoforms and involvement of cysteine residues in supramolecular assembly 30
null 30
In vitro and in vivo inhibition of SK-N-MC neuroblastoma growth using cyclic nucleotide phosphodiesterase inhibitors 29
Cellular Redox Metabolism Is Modulated by the Distinct Localization of Cyclic Nucleotide Phosphodiesterase 5A Isoforms 28
Wild-Type and Mutant FUS Expression Reduce Proliferation and Neuronal Differentiation Properties of Neural Stem Progenitor Cells 28
Phosphodiesterase-10A changes in basal ganglia circuits in two mouse genetic models of DYT1 Dystonia. 27
null 26
Hyper-expression of phosphodiesterase-10A in striato-nigral and striato-pallidal pathways of Torsin-A knock-in mice 25
Torsin-a DYT1-transgenic mice overexpress phosphodiesterase 10A in striato-nigral and striato-pallidal pathways. 24
null 24
Phosphodiesterase specific inhibitors control cell growth of a human neuroepithelioma cell line 23
Phosphodiesterase 10A and cyclic nucleotide catabolism in the physiopathology of experimental parkinsonism 22
Phosphodiesterase 4d depletion/inhibition exerts anti-oncogenic properties in hepatocellular carcinoma 16
Investigation on phosphodiesterase 10A control over D1-mediated facilitation of GABA release in the striato-nigral projections under normal and dopamine-depleted condictions in murine midbrain slices. 15
Levodopa induced alterations in cyclic nucleotide levels, a new aspect in the pathogenetic mechanism of Parkinson's disease 15
PDE10A is up-regulated in Enkephalin striatal projection neurons of a transgenic mouse model of DYT1 Dystonia 10
Phosphodiesterase 2A inhibition corrects the aberrant behavioral traits observed in genetic and environmental preclinical models of autism spectrum disorder 10
Amantadine prevents levodopa-induced dyskinesia by decreasing cyclic nucleotide phosphodiesterase activity 4
Levodopa-induced dyskinesia is associated with change in striatal cyclic nucleotides levels and cGMP hydrolyzing phosphodiesterase activity 4
Phosphodiesterase 4 specific inhibitors control cell growth of human hepatoma HepG2 cells. 4
null 1
Totale 2.891
Categoria #
all - tutte 7.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.191


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019320 0 0 0 0 0 0 0 0 0 64 142 114
2019/2020816 104 23 5 30 70 158 120 125 91 39 31 20
2020/2021277 31 25 15 17 2 30 5 10 36 66 18 22
2021/2022553 5 43 67 17 68 12 18 61 35 40 67 120
2022/2023420 110 103 17 30 34 12 12 15 38 24 18 7
2023/2024229 16 41 10 33 22 57 17 21 0 12 0 0
Totale 2.891